Showing 1,941 - 1,960 results of 133,317 for search '(( 2 c decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.86s Refine Results
  1. 1941
  2. 1942
  3. 1943
  4. 1944

    Decreased dermal and corneal stromal collagen in <i>Slc39a13</i>-KO mice. by Toshiyuki Fukada (156297)

    Published 2008
    “…Collagen of corneal stroma is decreased in <i>Slc39a13</i>-KO mice. H&E (left) and Azan (middle) staining show 5-week-old <i>Slc39a13</i>-KO cornea is thinner than wild-type littermates. …”
  5. 1945

    AT2R blocker reduces T3-induced decreased levels of contractile proteins and attenuates T3-induced NO production. by Maria Alícia Carrillo-Sepúlveda (406779)

    Published 2013
    “…Data are expressed as mean ± SD (n = 5 per group for A and B; n = 4 per group for C and D; *p<0.05 <i>vs.…”
  6. 1946
  7. 1947
  8. 1948
  9. 1949
  10. 1950

    The decreased stationary phase density of strains lacking pSymB in bulk soil is due to carbon limitation and can be traced to two loci. by George C. diCenzo (650171)

    Published 2014
    “…<p>(<b>A</b> – top panel) The strain with a deletion of B116 (orange) shows a slight, but repeatable, decrease in stationary phase density relative to the wild type (dark blue). …”
  11. 1951
  12. 1952

    Inhibition of TRPC3 decreases ATP- and OAG-induced Ca<sup>2+</sup> transients in striatal astrocytes. by Karin M. Streifel (653838)

    Published 2014
    “…Prior treatment with Pyr3 for 30 minutes at 37°C decreased the Ca<sup>2+</sup> response to ATP, whereas only a modest additive effect was observed with Pyr3 in the presence of 10 µM MPP<sup>+</sup>. …”
  13. 1953
  14. 1954
  15. 1955
  16. 1956
  17. 1957

    Ophthalmic administration of CXCR3 antagonist decreases intraocular pressure in a rat model of ocular hypertension. by Alexandre Denoyer (160189)

    Published 2012
    “…<i>(B)</i> When the antagonist is administrated twice, intraocular pressure remains low during 6 weeks (n = 10 each); the black arrow indicates the period of retinal and visual <i>in vivo</i> testing presented in <i>Fig. 6A,B</i>. <i>(C)</i> Dose-dependent effect of two administrations of CXCR3 antagonist on intraocular pressure as tested two weeks after the treatment (n = 5 each). * <i>P</i><0.05, ** <i>P</i><0.01. …”
  18. 1958
  19. 1959
  20. 1960